Wang J, Sicherer SH; SECTION ON ALLERGY AND IMMUNOLOGY. Guidance on Completing a Written Allergy and Anaphylaxis Emergency Plan. Pediatrics. 2017 Mar;139(3):e20164005. doi: 10.1542/peds.2016-4005. Epub 2017 Feb 13. PMID: 28193793.

 

Wasserman RL, Factor J, Windom HH, Abrams EM, Begin P, Chan ES, Greenhawt M, Hare N, Mack DP, Mansfield L, Ben-Shoshan M, Stukus DR, Leek TV, Shaker M. An Approach to the Office-Based Practice of Food Oral Immunotherapy. J Allergy Clin Immunol Pract. 2021 May;9(5):1826-1838.e8. doi: 10.1016/j.jaip.2021.02.046. Epub 2021 Mar 5. PMID: 33684637.

 

Jones SM, Kim EH, Nadeau KC, Nowak-Wegrzyn A, Wood RA, Sampson HA, Scurlock AM, Chinthrajah S, Wang J, Pesek RD, Sindher SB, Kulis M, Johnson J, Spain K, Babineau DC, Chin H, Laurienzo-Panza J, Yan R, Larson D, Qin T, Whitehouse D, Sever ML, Sanda S, Plaut M, Wheatley LM, Burks AW; Immune Tolerance Network. Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study. Lancet. 2022 Jan 22;399(10322):359-371. doi: 10.1016/S0140-6736(21)02390-4. PMID: 35065784; PMCID: PMC9119642.

 

Graham, François. Variations in protocol development during oral immunotherapy. Journal of Food Allergy (USA), Volume 4, Number 2, July 2022, pp. 86-97(12). doi: https://doi.org/10.2500/jfa.2022.4.220002

 

Fitzhugh, David J. Risk factors for reactions and adverse effects during oral immunotherapy. Journal of Food Allergy (USA), Volume 4, Number 2, July 2022, pp. 60-64(5). doi: https://doi.org/10.2500/jfa.2022.4.220028

​

​